Pharmaceutical Executive experienced in senior corporate management, including Executive Vice President Americas Operations Teva Pharmaceuticals and President and Chief Operating Officer Barr Laboratories, (subsidiary of Barr Pharmaceuticals Inc.). Extensive global experience in Merger & Acquisitions, global business integration, corporate management, and pharmaceutical operations.

President @ From December 2014 to Present (1 year 1 month) Pharmaceutical Executive @ From March 2014 to Present (1 year 10 months) Executive Vice President Americas Technical Operations @ Responsible for Operations in the Americas located throughout Latin America, the United States, and Canada employing over 7000 employees producing generic and proprietary pharmaceutical products. Created and managed an integrated operations network providing oral solid dose, injectible, biologics, inhalation, and liquid, cream & ointment products. Designed and led the integration of Operations for the Barr and Cephalon acquisitions. From April 2011 to February 2014 (2 years 11 months) Executive Vice President US Technical Operations @ Responsible for US Technical Operations From December 2008 to March 2011 (2 years 4 months) President & Chief Operating Officer @ Responsible for corporate management of global generic pharmaceutical operations with generic product sales of $1.8 billion and branded product sales of $400 million. Provided strategic corporate leadership for generic product selection and lifecycle management developing global business development opportunities, strategic product and API sourcing, and global operations optimization. Key personnel and decision maker related to patent litigation settlement and negotiation. From March 2008 to December 2008 (10 months) Executive Vice President, Global Product Supply @ Designed and managed the integration of U.S. and Rest of World operations following 2007, $2.6 billion acquisition of PLIVA, d.d. Developed an optimized global supply network with operations in the United States, Croatia, Poland, and the Czech Republic. Created a strategic active pharmaceutical ingredient (API) sourcing operation to provide a sustainable, competitive advantage for new product development. P&L responsibility for Pliva Active Pharmaceutical Ingredients (API) business. From October 2006 to March 2008 (1 year 6 months) President @ Corporate oversight and management of Pliva Subsidiary From 2007 to 2008 (1 year) Senior Vice President Manufacturing & Engineering @ From September 2001 to October 2006 (5 years 2 months) Vice President Validation & Technical Services @ From October 2000 to September 2001 (1 year) Vice President Operations & Facility General Manager @ Responsible for multi-site production and distribution operations. Planned and led the consolidation and integration of Copley’s operations into alternate Teva locations throughout the USA and Israel From December 1999 to October 2000 (11 months) Vice President Operations @ From October 1998 to December 1999 (1 year 3 months) Vice President Technical Services & Engineering @ From March 1998 to October 1998 (8 months) Senior Director Technical Services @ From September 1996 to March 1998 (1 year 7 months) Director Technology Transfer @ From October 1995 to September 1996 (1 year) Manager Business Development & Tableting Services @ From January 1995 to October 1995 (10 months) President & CEO @ Established and managed a start-up pharmaceutical company focused on sales and service of Korsch tablet compression equipment and contract development & manufacturing services. Korsch compression equipment became an innovative, industry leader while the contract services division worked on novel new drug development programs with companies such as Gilead Sciences, Chiron Vision, and KOS pharmaceuticals (Niaspan product). From January 1987 to December 1994 (8 years)

Master of Business Administration (M.B.A.), Business Administration and Management, General @ University of Pennsylvania - The Wharton School From 2001 to 2003 Master's Degree, Chemical Engineering @ Rutgers University, College of Engineering From 1983 to 1985 Bachelor's Degree, Chemical Engineering @ Rutgers University, College of Engineering From 1979 to 1983 Michael Bogda is skilled in: Drug Development, GMP, Technology Transfer, Biotechnology, Process Improvement, Clinical Development, Strategy, Pharmaceutical Industry, FDA, Start-ups, Managed Care, Oncology, Biopharmaceuticals, Product Development, Strategic Planning